Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Therapy \High Risk Prostate Cancer × proxalutamide × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castrate Resistant Prostate Cancer (mCRPC) 2 Severe Acute Respiratory Syndrome 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Neoadjuvant Therapy \High Risk Prostate Cancer 1 COVID-19 1 Alopecia 1

Interventions

proxalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05076851 2021-10-13

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Unknown

Neoadjuvant Therapy \High Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡